# In Vivo Evaluation of the Analgesic and Anti-Inflammatory Activity of Thymus numidicus Essential Oil

**Authors:** Ouardia Chaouchi, Velislava Todorova, Stanislava Ivanova, Elizabet Dzhambazova, Farida Fernane, Nacira Daoudi Zerrouki, Lyudmil Peychev, Kremena Saracheva, Michaela Shishmanova-Doseva, Zhivko Peychev

PMC · DOI: 10.3390/ph18071031 · 2025-07-11

## TL;DR

This study shows that Thymus numidicus essential oil has strong pain-relieving and anti-inflammatory effects in animal models.

## Contribution

The study provides new evidence for the analgesic and anti-inflammatory efficacy of Thymus numidicus essential oil in both acute and neuropathic pain models.

## Key findings

- Thymus numidicus essential oil significantly increased thermal threshold in hot-plate tests.
- The oil reduced paw volume in a dose-dependent manner in a plethysmometer test.
- It also improved withdrawal latency and threshold in a neuropathic pain model.

## Abstract

Background: Thymus numidicus Poiret. (Lamiaceae) is an endemic plant with well-known antibacterial properties. It has been largely used in traditional Algerian medicine. This study aimed to compare the chemical composition of essential oils (EOs) extracted from leaves and flowers using the gas chromatography–mass spectrometry method, as well as to investigate its analgesic and anti-inflammatory activities. Results: The EOs were rich in monoterpenes and classified as a thymol chemotype. In vivo experiments revealed that acute treatment with T. numidicus EO (20 and 80 mg/kg) significantly increased the thermal threshold on the hot-plate at all tested hours compared to the control animals (p < 0.001, respectively), while only the higher dose had a similar effect to the metamizole group at 2 and 3 h. In the mechanical stimulus test, both doses of the EO led to a late analgesic effect presented with increased paw withdrawal threshold only during the third hour compared to the control group (p < 0.05, respectively). In the plethysmometer test both doses of the EO dose-dependently reduced paw volume with nearly 10% and 15% compared to the control animals at all tested hours (p < 0.001, respectively), with a more pronounced volume reduction in the higher dose. In a neuropathic pain model, the EO (20 mg/kg and 80 mg/kg) dose-dependently increased the withdrawal latency time towards thermal stimuli and enhanced the paw withdrawal threshold in response to mechanical pressure at all tested hours compared to the CCI-group (p < 0.001, respectively). These findings demonstrate the potent analgesic and anti-inflammatory effects of T. numidicus EO in models of acute and neuropathic pain.

## Linked entities

- **Chemicals:** thymol (PubChem CID 6989)

## Full-text entities

- **Diseases:** neuropathic pain (MESH:D009437), Inflammatory (MESH:D007249), acute and neuropathic pain (MESH:D059787)
- **Chemicals:** metamizole (MESH:D004177), T. numidicus EO (-), EO (MESH:D009822), thymol (MESH:D013943), monoterpenes (MESH:D039821)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12300282/full.md

---
Source: https://tomesphere.com/paper/PMC12300282